Comparison of Diagnostic Value Between STE+LDDSE and CMR-FT for Evaluating Coronary Microvascular Obstruction in Post-PCI Patients for STEMI.

Tao LiuChaofan WangJie YinLili WangHaochen XuanYan YanJunhong ChenJieli BaoDongye LiTongda Xu

Published in: Therapeutics and clinical risk management (2022)

Low-dose dobutamine can improve the clinical value of STE for evaluating CMVO in STEMI patients. Compared with CMR-FT, STE+LDDSE might be a better choice for STEMI patients because of its safety, convenience, and low-cost.

Keyphrases

end stage renal disease
low dose
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
st elevation myocardial infarction
coronary artery
acute coronary syndrome
st segment elevation myocardial infarction
high dose
coronary artery bypass grafting
coronary artery bypass